Contrast Induced Nephropathy- A Single Centre Observational Study

Main Article Content

Rohit Rai
Rahul Singla
Shakil S. Shaikh
Narender O. Bansal


Background: CIN is an important cause of morbidity and mortality post cardiac procedures. Renal derangement and diabetes being the most important risk factors. Multifactorial causation of the disorder led us to study the risk factors associated with CIN.

Methods: All patients who underwent cardiac procedures between March 2019 and March 2020 were screened for CIN and included in the study. Out of the 3192 patients screened 99 patients were diagnosed with CIN. Parameters such as diabetes mellitus, hypertension, CKD, anemia, duration of hospital stay, cardiogenic shock, number of stents, amount and type of contrast, Ejection Fraction, creatinine clearance before and after the procedure, concomitant nephrotoxic drugs were also recorded. 

Results: Ninety-nine patients developed CIN amounting to 3% of the total procedures, 11% expired, 18% required dialysis, average creatinine clearance before the procedure was 53.15 ml/min/1.73 m2 and post procedure it was 29.16 ml/min/1.73 m2, 51.5% of cases had creatinine clearance prior to procedure <60 ml/min/1.73 m2, 60.6% were diabetic, 81.8% were hypertensive, 30.3% were anaemic, 15% had heart failure, 33% required ventilatory assistance, average haemoglobin level was 11.83 mg/dl, 33% received iso-osmolar contrast and 45% had EF of 35% or less.

Conclusions: CIN has a multifactorial causation most common being prior renal derangement and diabetes mellitus. This is one of a kind study in this part of country among cardiac patients. Newer biomarkers of kidney injury could also be studied in future.

Contrast Induced Nephropathy (CIN), diabetes mellitus, kidney disease.

Article Details

How to Cite
Rai, R., Singla, R., Shaikh, S. S., & Bansal, N. O. (2020). Contrast Induced Nephropathy- A Single Centre Observational Study. Cardiology and Angiology: An International Journal, 9(4), 38-42.
Original Research Article


Sudarsky D, Nikolsky E. Contrast-induced nephropathy in interventional cardiology. International Journal of Nephrology and Renovascular Disease. 2011;4:85.

Parfrey P. The clinical epidemiology of contrast-induced nephropathy. Cardiovascular and Interventional Radiology. 2005;28(2):S3-11.

American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183e1197.

World Health Organization. Nutritional anemia: Report of a WHO scientific group. Geneva, Switzerland: World Health Organization; 1968.

Gruberg L, Mehran R, Dangas G, Mintz GS, Waksman R, Kent KM, Pichard AD, Satler LF, Wu H, Leon MB. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheterization and Cardiovascular Interventions. 2001;52(4): 409-16.

Rudnick MR, Leonberg-Yoo AK, Litt HI, Cohen RM, Hilton S, Reese PP. The controversy of contrast-induced nephropathy with intravenous contrast: What is the risk? American Journal of Kidney Diseases. 2020;75(1):105-13.

McCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. The American Journal of Medicine. 1997; 103(5):368-75.

Ribitsch W, Horina JH, Quehenberger F, Rosenkranz AR, Schilcher G. Contrast induced acute kidney injury and its impact on mid-term kidney function, cardiovascular events and mortality. Scientific Reports. 2019;9(1):1-7.

Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. Journal of the American College of Cardiology. 2004;44(7):1393-9.

Jeon J, Kim S, Yoo H, Kim K, Kim Y, Park S, et al. Risk prediction for contrast-induced nephropathy in cancer patients undergoing computed tomography under preventive measures. Journal of Oncology; 2019.

Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. The American Journal of Cardiology. 2005;95(1):13-9.

Evola S, Lunetta M, Macaione F, Fonte G, Milana G, Corrado E, et al. Risk factors for contrast induced nephropathy: A study among Italian patients. Indian Heart Journal. 2012;64(5):484-91.

Caspi O, Habib M, Cohen Y, Kerner A, Roguin A, Abergel E, et al. Acute kidney injury after primary angioplasty: IS contrast‐induced nephropathy the culprit?. Journal of the American Heart Association. 2017;6(6):e005715.

Iakovou I, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. The Journal of Invasive Cardiology. 2003; 15(1):18-22.

Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105(19): 2259-64.

Toprak O, Cirit M, Yesil M, Bayata S, Tanrisev M, Varol U, et al. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Nephrology Dialysis Transplantation. 2007;22(3):819-26.

Ahuja TS, Niaz N, Agraharkar M. Contrast-induced nephrotoxicity in renal allograft recipients. Clinical Nephrology. 2000;54(1): 11-4.

Davenport MS, Perazella MA, Yee J, Dillman JR, Fine D, McDonald RJ, et al. Use of intravenous iodinated contrast media in patients with kidney disease: Consensus statements from the American College of Radiology and the National Kidney Foundation. Radiology. 2020; 294(3):660-8.